Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy

scientific article published on 01 August 2020

Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1126/SCITRANSLMED.AAZ6606
P698PubMed publication ID32801144

P50authorRobert S. Langer, Jr.Q669597
Kevin J McHughQ59423412
Ana JaklenecQ59423416
Kaitlyn SadtlerQ88258658
Daniel G AndersonQ88674786
Zachary L TochkaQ88988731
Stephanie TomasicQ88988732
Xueguang LuQ91271861
Tyler GrafQ91271863
Yuxuan HuangQ98499101
Morteza SarmadiQ98499102
P2093author name stringLei Miao
Quanyin Hu
Ziqi Chen
Yehui Sun
Wenting Gao
Alain Hyacinthe
P433issue556
P921main subjectimmunotherapyQ1427096
bites and stingsQ54911704
P577publication date2020-08-01
P1433published inScience Translational MedicineQ1573955
P1476titleEngineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
P478volume12